Weather Alert  

"Special Statement" ...Areas of black ice into Thursday morning... Temperatures will fall into the teens for most of the area tonight. This will cause moisture or slush on untreated surfaces to freeze, resulting in areas of black ice. Extra caution should be used if traveling, particularly on sidewalks, driveways, parking lots, and secondary roads. 1149 PM EST Wed Jan 17 2018 ...Areas of black ice into Thursday morning... Temperatures will fall into the teens for most of the area tonight. This will cause moisture or slush on untreated surfaces to freeze, resulting in areas of black ice. Extra caution should be used if traveling, particularly on sidewalks, driveways, parking lots, and secondary roads. -- Thursday Jan.18 18,06:49 AM

A.G. Schneiderman Launches Antitrust Investigation into Mylan Pharmaceuticals, Maker of EpiPen

LongIsland.com

A preliminary review revealed that Mylan Pharmaceuticals may have inserted potentially anticompetitive terms into its EpiPen sales contracts with numerous local school systems.

Print Email

Attorney General Eric T. Schneiderman: "No child’s life should be put at risk because a parent, school, or healthcare provider cannot afford a simple, life-saving device because of a drug-maker’s anti-competitive practices."

Photo by: Anissa Thompson, via Free Images.

New York, NY - September 6, 2016 - Today, Attorney General Eric T. Schneiderman announced his office has commenced an investigation into Mylan Pharmaceuticals Inc, the maker of EpiPens. A preliminary review by the Office of the Attorney General revealed that Mylan Pharmaceuticals may have inserted potentially anticompetitive terms into its EpiPen sales contracts with numerous local school systems. Mylan’s EpiPen is the predominant epinephrine autoinjector—a device and drug used in cases where an individual suffers a severe allergic reaction, which could otherwise lead to death—in the U.S. market.

“No child’s life should be put at risk because a parent, school, or healthcare provider cannot afford a simple, life-saving device because of a drug-maker’s anti-competitive practices,” Attorney General Eric T. Schneiderman said.  “If Mylan engaged in anti-competitive business practices, or violated antitrust laws with the intent and effect of limiting lower cost competition, we will hold them accountable. Allergy sufferers have enough concerns to worry about—the availability of life-saving medical treatment should not be one of them. I will bring the full resources of my office to this critical investigation.”